Kada Mohammed S, Billa O, Ladoire S, Jankowski C, et al. HER2-positive invasive lobular carcinoma: a rare breast cancer which may not necessarily require anti-HER2 therapy. A population-based study. Breast Cancer 2023 Jan 30. doi: 10.1007/s12282-022-01432.
PMID: 36715845